The Importance of Clinical Data for the Medical Cannabis Industry
FREMONT, CA – Over the last few years, the clinical data regarding medical cannabis research has burgeoned, necessitating the development of robust systems to analyze critical information. The obstacles hindering the study have been swept aside with the legalization of cannabis consumption for medical and recreational purposes in numerous states across the U.S.
For many years, most of the cannabis-based research was conducted in Israel, and later on, in Canada. The emergence of new markets has sparked new potential for cannabis research. However, accurate data regarding cannabis is required by researchers, physicians, and other stakeholders. In this regard, many organizations in the cannabis sector are collaborating with data technology companies to develop data systems. The cannabis-based systems will aid medical professionals and researchers to keep track of the relevant information.
Check This Out: Top Clinical Data Management Companies
With the opioid crisis plaguing the world of medicine, many organizations are turning toward cannabis as a potential replacement. Several states, including New York, Pennsylvania, and New Jersey are allowing the use of cannabis for pain treatments. Since the successful use of cannabis-based treatment on children suffering from epileptic disorders, many medical organizations are delving into the troves of clinical data to determine the effectiveness of cannabis treatments for different conditions.
The increase in demand for medical cannabis, even among the patients, is driving the growth of the industry. By the year 2023, the global medical cannabis industry is expected to rise to $37 billion at a rate of 22 percent from $11 billion in the year 2017. According to a survey conducted among the clinics, there is an increase in the number of customers inquiring about medical cannabis. Hence, it is imperative that medical institutions have access to accurate clinical information regarding cannabis.
Researchers have come a long way in narrowing the gap in the medical knowledge created by the legal barriers regarding the use of cannabis. The emergence of data solutions has enabled medical professionals to gather a vast amount of information to aid in their treatments. As the research progresses, medical professionals will need focused access to specific information to bolster their medical decisions.
By Linda H. Butler, VP of Medical Affairs/CMO/CMIO, Rex...
By Laura Cruz, Global CIO, MDC Partners
By Greg Morrison, SVP & CIO, Cox Enterprises
By Lowell Gilvin, Chief Process Officer, Jabil
By Joe LaFeir, SVP, IS&S (Information Systems & Solutions),...
By Gerri Martin-Flickinger, CIO, Adobe Systems
By Aaron Weis, VP & CIO, Axalta Coating Systems
By Levon Hooks, CIO-Global Corporate Solutions, JLL
By Steve Bein, VP-GIS, Michael Baker International
By Sam Schoelen, Chief Information Technology Officer,...
By Georgios Kyriakopoulos, VP of Equity Research, SunTrust...
By David Sliter, VP & GM of Communications, Media &...
By Julie Stafford, SVP Strategic Consulting, Tangoe
By Dan Adam, CIO, Extreme Networks
By Scott Craig, Vice President of Product Marketing, Lexmark...
By Aaron Gette, CIO, The Bay Club Company
By Dr. Volker G. Hildebrand, Global VP, SAP Hybris
By Meerah Rajavel, CIO, Forcepoint
By Philip Loftus, SVP IT & CIO, SSM Health
By Christy Hartner, SVP, Commerce Bank